Osimertinib: Another medication related to osteonecrosis of the jaws? A case report and literature review
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is an oral complication in cancer patients being treated with either antiresorptives, mainly denosumab and bisphosphonates, or antiangiogenic drugs. Osimertinib is a third-generation epidermal growth factor receptor (EGFR)-tyrosine ki...
Saved in:
Main Authors: | Feng Wang (Author), Shengnan Wei (Author), Zexuan Zhang (Author), Yuan Zhang (Author), Jingya He (Author), Bin Sun (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?
by: Andrea Cassoni, et al.
Published: (2016) -
Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018) -
Medication-related osteonecrosis of the jaw-A case report and literature review
by: Chieh Chen, et al.
Published: (2023) -
Pharmacoepidemiology and clinical characteristics of medication-related osteonecrosis of the jaw
by: Hyo-Jeong Son, et al.
Published: (2019) -
Current treatment approaches in medical-related osteonecrosis of the jaw: Literature review
by: Buse KORKUT, et al.
Published: (2022)